169 related articles for article (PubMed ID: 33802613)
1. A Smart Hyperthermia Nanofiber-Platform-Enabled Sustained Release of Doxorubicin and 17AAG for Synergistic Cancer Therapy.
Chen L; Fujisawa N; Takanohashi M; Najmina M; Uto K; Ebara M
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33802613
[TBL] [Abstract][Full Text] [Related]
2. Hyperthermia Nanofiber Platform Synergized by Sustained Release of Paclitaxel to Improve Antitumor Efficiency.
Niiyama E; Uto K; Lee CM; Sakura K; Ebara M
Adv Healthc Mater; 2019 Jul; 8(13):e1900102. PubMed ID: 31091019
[TBL] [Abstract][Full Text] [Related]
3. An implantable smart magnetic nanofiber device for endoscopic hyperthermia treatment and tumor-triggered controlled drug release.
Sasikala ARK; Unnithan AR; Yun YH; Park CH; Kim CS
Acta Biomater; 2016 Feb; 31():122-133. PubMed ID: 26687978
[TBL] [Abstract][Full Text] [Related]
4. Doxorubicin hydrochloride - Loaded electrospun chitosan/cobalt ferrite/titanium oxide nanofibers for hyperthermic tumor cell treatment and controlled drug release.
Radmansouri M; Bahmani E; Sarikhani E; Rahmani K; Sharifianjazi F; Irani M
Int J Biol Macromol; 2018 Sep; 116():378-384. PubMed ID: 29723626
[TBL] [Abstract][Full Text] [Related]
5. Multifunctional Nanocarpets for Cancer Theranostics: Remotely Controlled Graphene Nanoheaters for Thermo-Chemosensitisation and Magnetic Resonance Imaging.
Ramachandra Kurup Sasikala A; Thomas RG; Unnithan AR; Saravanakumar B; Jeong YY; Park CH; Kim CS
Sci Rep; 2016 Feb; 6():20543. PubMed ID: 26841709
[TBL] [Abstract][Full Text] [Related]
6. Graphene Quantum Dots-Capped Magnetic Mesoporous Silica Nanoparticles as a Multifunctional Platform for Controlled Drug Delivery, Magnetic Hyperthermia, and Photothermal Therapy.
Yao X; Niu X; Ma K; Huang P; Grothe J; Kaskel S; Zhu Y
Small; 2017 Jan; 13(2):. PubMed ID: 27735129
[TBL] [Abstract][Full Text] [Related]
7. Fabrication of carboxymethyl chitosan/poly(ε-caprolactone)/doxorubicin/nickel ferrite core-shell fibers for controlled release of doxorubicin against breast cancer.
Abasalta M; Asefnejad A; Khorasani MT; Saadatabadi AR
Carbohydr Polym; 2021 Apr; 257():117631. PubMed ID: 33541657
[TBL] [Abstract][Full Text] [Related]
8. Mesoporous γ-Iron Oxide Nanoparticles for Magnetically Triggered Release of Doxorubicin and Hyperthermia Treatment.
Benyettou F; Ocadiz Flores JA; Ravaux F; Rezgui R; Jouiad M; Nehme SI; Parsapur RK; Olsen JC; Selvam P; Trabolsi A
Chemistry; 2016 Nov; 22(47):17020-17028. PubMed ID: 27739116
[TBL] [Abstract][Full Text] [Related]
9. Magnetic hyperthermia and pH-responsive effective drug delivery to the sub-cellular level of human breast cancer cells by modified CoFe
Oh Y; Moorthy MS; Manivasagan P; Bharathiraja S; Oh J
Biochimie; 2017 Feb; 133():7-19. PubMed ID: 27916642
[TBL] [Abstract][Full Text] [Related]
10. Folate receptor-targeted hybrid lipid-core nanocapsules for sequential delivery of doxorubicin and tanespimycin.
Gupta B; Pathak S; Poudel BK; Regmi S; Ruttala HB; Gautam M; Lee JS; Jeong JH; Choi HG; Yong CS; Kim JO
Colloids Surf B Biointerfaces; 2017 Jul; 155():83-92. PubMed ID: 28410515
[TBL] [Abstract][Full Text] [Related]
11. Doxorubicin-Loaded Thermoresponsive Superparamagnetic Nanocarriers for Controlled Drug Delivery and Magnetic Hyperthermia Applications.
Ferjaoui Z; Jamal Al Dine E; Kulmukhamedova A; Bezdetnaya L; Soon Chang C; Schneider R; Mutelet F; Mertz D; Begin-Colin S; Quilès F; Gaffet E; Alem H
ACS Appl Mater Interfaces; 2019 Aug; 11(34):30610-30620. PubMed ID: 31359758
[TBL] [Abstract][Full Text] [Related]
12. Schedule-dependent synergy between the heat shock protein 90 inhibitor 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin and doxorubicin restores apoptosis to p53-mutant lymphoma cell lines.
Robles AI; Wright MH; Gandhi B; Feis SS; Hanigan CL; Wiestner A; Varticovski L
Clin Cancer Res; 2006 Nov; 12(21):6547-56. PubMed ID: 17085670
[TBL] [Abstract][Full Text] [Related]
13. Magnetic nanoparticles for amalgamation of magnetic hyperthermia and chemotherapy: An approach towards enhanced attenuation of tumor.
Singh A; Jain S; Sahoo SK
Mater Sci Eng C Mater Biol Appl; 2020 May; 110():110695. PubMed ID: 32204010
[TBL] [Abstract][Full Text] [Related]
14. Preparation and Evaluation of Doxorubicin-Loaded PLA-PEG-FA Copolymer Containing Superparamagnetic Iron Oxide Nanoparticles (SPIONs) for Cancer Treatment: Combination Therapy with Hyperthermia and Chemotherapy.
Khaledian M; Nourbakhsh MS; Saber R; Hashemzadeh H; Darvishi MH
Int J Nanomedicine; 2020; 15():6167-6182. PubMed ID: 32922000
[TBL] [Abstract][Full Text] [Related]
15. An implantable smart hyperthermia nanofiber with switchable, controlled and sustained drug release: Possible application in prevention of cancer local recurrence.
Samadzadeh S; Babazadeh M; Zarghami N; Pilehvar-Soltanahmadi Y; Mousazadeh H
Mater Sci Eng C Mater Biol Appl; 2021 Jan; 118():111384. PubMed ID: 33254991
[TBL] [Abstract][Full Text] [Related]
16. A facile, flexible, and multifunctional thermo-chemotherapy system for customized treatment of drug-resistant breast cancer.
Chen L; Nabil A; Fujisawa N; Oe E; Li K; Ebara M
J Control Release; 2023 Nov; 363():550-561. PubMed ID: 37804880
[TBL] [Abstract][Full Text] [Related]
17. Biocompatible superparamagnetic core-shell nanoparticles for potential use in hyperthermia-enabled drug release and as an enhanced contrast agent.
Patil-Sen Y; Torino E; De Sarno F; Ponsiglione AM; Chhabria V; Ahmed W; Mercer T
Nanotechnology; 2020 Sep; 31(37):375102. PubMed ID: 32392545
[TBL] [Abstract][Full Text] [Related]
18. Magnetically triggered nanovehicles for controlled drug release as a colorectal cancer therapy.
Kuo CY; Liu TY; Chan TY; Tsai SC; Hardiansyah A; Huang LY; Yang MC; Lu RH; Jiang JK; Yang CY; Lin CH; Chiu WY
Colloids Surf B Biointerfaces; 2016 Apr; 140():567-573. PubMed ID: 26705859
[TBL] [Abstract][Full Text] [Related]
19. MOF-derived novel porous Fe
Xiang Z; Qi Y; Lu Y; Hu Z; Wang X; Jia W; Hu J; Ji J; Lu W
J Mater Chem B; 2020 Sep; 8(37):8671-8683. PubMed ID: 32856668
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of Doxorubicin loaded magnetic chitosan nanoparticles for pH responsive targeted drug delivery.
Unsoy G; Khodadust R; Yalcin S; Mutlu P; Gunduz U
Eur J Pharm Sci; 2014 Oct; 62():243-50. PubMed ID: 24931189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
